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 Abstract 
This master thesis analyzes the technical and economical feasibility for a 
medical database, based on clinically generated data of patients with the 
fibromyalgia syndrome. The main idea is to collect patient data on a regular 
basis during standard visiting hours at their doctor. Therefore it is essential to 
provide a data collection platform that can be simply used by the patient and 
doctor. 
The collected information (no personal data) shall be shared between 
researchers to enhance collaborative studies, make studies with rare diseases 
possible as well as to reduce the cost and effort to gather a big enough cohort 
group for the study. 
There are already several medical databases in place that collect and share 
patient information for research. Yet, despite the significant socioeconomic 
impact of fibromyalgia, no large database about this disease exists. 
An introduction to the fibromyalgia syndrome and its impact on society are 
given. Furthermore medical database technologies and medical database 
projects for other diseases are described. 
The presented technologies are further analyzed for their usefulness of 
creating a database to collect information about fibromyalgia syndrome 
patients and to use it to enhance its research. Additionally the legal 
requirements for maintaining such a platform as well as the potential cost are 
examined. Two possible business models to provide such a platform with 
funding are presented. 
Last but not least a possible use case for the collection of patient data via a 
survey created with REDCap and the integration process into i2b2 has been 
created and possible suggestions for improvements in the future have been 
made to bring the platform to a release ready state. 
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INTRODUCTION 
In our society a healthy life plays an important role. The fibromyalgia syndrome 
has a strong socioeconomic impact onto our society. It has a severe impact 
onto people’s everyday life and lowers their quality of life dramatically. This is 
accompanied by a high economic impact as well because it affects the people’s 
ability to follow their jobs. Yet the knowledge about fibromyalgia is fairly limited if 
it comes to awareness about the disease as well as about the most effective 
medical treatments. In order to tackle these challenges it is of high importance 
to collect as much information about the disease as possible and to make it 
accessible to research. 
The general objective is to conduct a technical and business feasibility study for 
the creation of a database based on clinically generated data of patients with 
the fibromyalgia syndrome. Such a platform should be used to gather patient 
data in a simple and secure way according to GDPR and data and privacy 
regulations of each participating country within the European Union. 
The first objective is an introduction to the fibromyalgia syndrome, its medical 
symptoms, worldwide occurrence and the impact it has on the patient’s quality 
of life as well as its socioeconomic impact on society as a whole. Furthermore a 
short overview about fibromyalgia research, hence the motivation for creating 
such a patient database is given. 
The second objective is to give an overview about the status of existing 
fibromyalgia syndrome databases and current state of the art database 
technology that is available on the market to deal with medical patient and 
privacy sensitive data. 
The third objective is to conduct a feasibility study out of the technical 
perspective. This entails a thorough analysis of already existing database 
technologies and how they could be applied for the specific use case of a 
fibromyalgia patient data. 
The fourth objective is to conduct a feasibility study out of an economical and 
legal point of view. Next to the technical challenges for a fibromyalgia patient 
database possible business models as well as privacy and data protection 
rights (e.g. General Data Protection Regulation (GDPR) in the European Union) 
shall be analyzed. 
The fifth objective is to prepare a simplified use case to show how patient data 
can be collected and stored inside a database. This shall give the proof of 
concept for such a fibromyalgia patient database. 
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1. Introduction to fibromyalgia 
This chapter gives a basic overview about the fibromyalgia syndrome (from 
hereon called FMS), its symptoms and the magnitude of impact it has on 
society. Furthermore, some basic concepts in the medical analysis and 
research of the fibromyalgia syndrome are introduced to prepare the reader for 
the motivation of creating such a database platform. Moreover, at the end of the 
chapter the research objectives of a consortium of organizations whose aim is 
to tackle several challenges of FMS will be explained. 
1.1.What is fibromyalgia 
FMS is a disease, which is mainly characterized by chronic pain. The symptoms 
and signs can vary widely in form and strengths depending on the patient’s 
mental and physical state. The first definition of FMS in 1990 by the American 
College of Rheumatology (from hereon ACR) was based on ruling out other 
potential diseases and causes for the patient’s condition as well as checking for 
the presence of specific FMS symptoms. 
The treatment commonly consists of spa therapy, aerobic exercise, cognitive 
behavioral therapy and the drug Amitriptyline . 1
Even though FMS nowadays is understood relatively well the pathogenesis  of 2
FMS is still unknown. Furthermore, the diagnosis, classification and treatment of 
FMS remain controversial.[1] 
1.1.1.Overview of the symptoms and diagnosis 
FMS is a disease, which has a big variety of symptoms and can affect both the 
body as well as the mind of a patient suffering from the condition. The 
symptoms are very diverse and can include restless sleep, headaches and 
mood disturbances to just name a few. A more detailed description of the 
symptoms can be found in Annexes A1. 
The most common definition of FMS nowadays is the 2010 approved diagnostic 
criteria by the ACR. The 2010 criteria should make it easier to be used in 
primary care and introduced a scale for the severity of the symptoms based on 
 Amitriptyline is a medication which main purpose is the treatment of different mental diseases, 1
such as depressive or anxiety disorders.
 Pathogenesis is the biological mechanism of a disease and can also describe its development 2
and origin.
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the characteristics of FMS.[2] Therefore the 2010 definition of FMS uses indices 
and categorical scales. This makes the storage in a database and the 
processing of this information easier for a mathematical model, because the 
data variables can be stored in a numerical way of for the symptom description. 
In order to evaluate the symptoms of FMS the ACR uses a widespread pain 
index (WPI) and a severity scale (SS). The WPI is used to describe the pain of 
up to 19 areas of the body in which the patients experienced pain in the 
previous week. The WPI is categorized into the category groups 0,1,2 and 3 
which each can have a score of 0-3 and a cumulative score of 0-12.[2] 
The SS is used to assess the level of the patient’s symptoms with a score 
between 0 and 3 for un-refreshed awaking, fatigue, somatic  and cognitive 3
symptoms. 
According to the 2010 criteria a diagnosis of FMS is satisfied if the following 
three conditions are present in the patient [2]: 
• (WPI of 3 - 6 and SS ≥ 9) OR (WPI ≥7 and SS ≥ 5). 
• The symptoms have to be present for at least 3 months at a constant 
level. 
• No other disorder can explain the patient’s pain. 
1.1.2.Occurrence and (economic) impact on society 
It is assumed by population-based studies that between 7% to 11% of the 
world’s population suffer of chronic widespread pain and about 1% to 5% of 
FMS. Over 90% of the people affected with FMS are women in the age range of 
20 to 50. 
FMS impairs the patient's quality of life, causes stress and therefore leads to 
considerable direct and indirect costs for the disease.[1] It is said that compared 
to patients of other chronic pain syndromes the health-related quality of life for 
patients with FMS is lowere. [3] 
A study from 2012 analyzed several databases, scientific papers and literature 
on the prevalence of chronic pain conditions and their related costs within the 
European Union[4]: 
• 20% to 50% of persons with FMS were unable to work.  
• 50 % received social payments. 
• Of all chronic pain conditions FMS causes the highest rate of 
unemployment (6%) and the greatest number of days absent from work. 
 Somatic can describe a variety of symptoms related the nervous system. This can include 3
pain, nausea, vertigo, etc.
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Experts in general agree that the prevalence of FMS is increasing and also that 
it is causing an enormous financial burden. Nevertheless, sufficient evidence to 
support these claims is missing. 
A study conducted in Canada, in 1999, yielded that the cost and utilization of 
medical services is double for patients suffering from FMS compared to patients 
suffering of widespread pain. [5] 
A US study from 2007 showed that the healthcare costs of FMS patients are 
three times as high as compared to the control group of randomly selected 
patients from a health insurance database. 
A study of Sicras-Mainar and his team compared the incremental cost of FMS 
patients caused by utilization of healthcare but also non-healthcare resources, 
comparing these costs to a reference group using European primary care. The 
incremental costs of FMS patients compared to the reference group is €5000 
higher, whereas only 600€ are contributed to the use of healthcare resources. 
Furthermore, according to the same study, patients suffering from FMS show a 
higher occurrence of comorbidities, a higher number of average workdays 
missed as well as six more visits to the doctor per year when comparing them to 
the reference population group. [6] 
A study conducted in the Netherlands calculated the average annually 
socioeconomic costs caused per patient for different musculoskeletal diseases. 
It states: €8533 for chronic low back pain, €7813 for FMS and €3205 for 
ankylosing spondylitis . Central causes for higher costs for FMS and chronic 4
low back pain have been attributed to the lost ability to perform work, aids, 
adaptations and care-taking. Moreover, FMS and chronic low back pain also 
score lower in terms of well-being.[7] 
When taking these numbers into consideration, assuming that 3% of the 
population suffers from FMS on average, the total annual cost of FMS would be 
around €12 billion for a country like Germany with a population of 80 million 
people and around €6.9 billion for Spain with a population of 46 million people, 
of which only €960 million and €552 million respectively are contributed by 
pharmacological treatment. Having in mind that these numbers only represent 
the additional costs for FMS compared to the populations reference group the 
total absolute cost of FMS can be assumed to be approximately €18.8 billion for 
Germany and €10.8 billion for Spain annually.[6] Furthermore, since these 
studies date back to the years of 2004 and 2009 an even higher number can be 
expected for the year 2018.  
It is apparent that FMS not only has a big economical impact on society but 
also on the quality of life for people suffering from it. Hence, efforts in the 
medical research for FMS should be directed into decreasing the cost of the 
FMS treatments and increasing the patties quality of life. 
 It is a form of arthritis accompanied by a long-term inflammation of the spine and the joints.4
!   Master Thesis Tobias Joschko5
1.2.Research on FMS 
  
The magnitude of impact of FMS is not yet completely understood in every 
detail. Sometimes people might not even realize that they suffer from FMS. 
Therefore research should analyze the socioeconomic impact of FMS as well as 
to increase the understanding of the symptoms and course of the disease. 
Furthermore each country with a different healthcare systems should aim to use 
the latest data available to provide more efficient evidence based treatment for 
FMS patients. 
At the moment not many databases for FMS exist and some of the data they 
contain is inconsistent. There is a lack in consistency of the assessment tools, 
deviation in the reference groups and studies with outdated information 
because the research has been done more than a decade ago. Furthermore, 
the diversity of medical systems and different political environment in each 
country needs to be taken into consideration as well.[6] 
In most cases the treatment of FMS remains difficult for the physician, and the 
patients tend to not be satisfied with the outcome. A novel therapeutic concept 
which could be used for blocking comorbidity is called altering course of FMS. 
In order to apply approaches to alter the course of FMS it is important to 
perform patient stratification . Patients could be grouped by separating them 5
based on measures for psychological and symptomatic symptoms. Subgroup 
classifications based on empirical studies are essential so as to provide more 
specific therapies.[8] Even though there have been prior attempts in order for 
classification of patients, there are no clinical variables or clear patient 
subgroups defined yet.[9] 
A proper categorization of a disease into different subgroups requires the 
existence of large database containing sufficient patient data. Such a database 
does not exist at the moment. 
1.2.1.Research objectives 
A research consortium of different research groups from the Universitat 
Politècnica de Catalunya (UPC), Spain, Hospital de Terrasa (CST), Spain, the 
University Hospital of Riga Stradins University (RSU), Latvia and the 
Universitätsklinikum in Essen (UK Essen), Germany aims to apply a novel 
approach of altering the course of FMS by pooling the resources of an 
interdisciplinary collaboration. 
The approach of altering the course of FMS aims to mitigate the effects of 
psychological symptoms and mental disorder comorbidities related to FMS or to 
 Stratification in a medical research context describes the grouping of patients by a factor, 5
which is different from the current treatment given.
Introduction to fibromyalgia  !6
even completely avoid its development. In order to establish this new approach 
several goals of the project are defined: 
1. Quantitative identification of the relationship of psychological symptoms 
and mental comorbidities with FMS. 
2. Utilization of a mathematical model in order to describe the appearance 
of psychological symptoms, as well as mental disorder comorbidities with 
FMS. 
3. Utilization of quantitative criteria, validated by a database containing 
measurements of somatic and mental health, to stratify FMS patients. 
4. Creation of an anonymized FMS patient database containing variables 
about the following data types: somatic symptoms, sociodemographics, 
lifestyle, treatment, data about psychological and mental health, 
genetics, neuroimaging and neurochemistry. 
5. The long-term goal is the provision of individually tailored and effective 
therapeutic or preventive approaches to reduce the functional impact and 
improve the mental health of patients suffering from FMS. 
The mental disorders and psychological comorbidities with FMS in addition to 
its insufficiently understood pathogenesis make the prevention and treatment of 
FMS difficult and problematic.[10] Hence, to reach a better understanding of the 
pathogenesis and alter the course of FMS, new and innovative methods 
benefitting from interdisciplinary cooperation, are necessary. 
1.2.2.Monte Carlo Analysis  
The gathered patient variables in the database will be analyzed regarding their 
relevance for the inception of FMS and probability distributions will be 
generated for each variable. A comparison of the derived probability 
distributions shall be done with relevant literature. Moreover, probability 
distributions for the previously selected variables will be gathered for a 
reference group not suffering from FMS. The Monte Carlo Analysis method will 
be used to create simulated individuals utilizing both probability distributions. In 
order to describe the impact of each analyzed variable on mental disorder 
comorbidities, a mathematical model will be proposed. Therefore, it will be 
possible for each of the simulated individuals to predict an impact score the 
patient will have for each mental disorder comorbidity. 
In addition, the mathematical model shall be used to stratify the patients into 
different subgroups.  
Comparing the statistical distribution for mental disorder comorbidities of the 
simulated patients against the real patients gathered in the database will 
perform a validation of the model. [10] 
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1.3.Motivation to create an FMS database 
As of today, no comprehensive database for FMS patient data exists. 
Researches mostly can only use their individually created and mostly relatively 
small databases. In order to classify and categorize patients into subgroups for 
comorbidity studies a much larger and more comprehensive database is 
needed. 
Further the grouping of FMS patients with such a novel method shows potential 
to be useful for other heterogeneous and chronic psychiatric conditions, such as 
bipolar disorder, schizophrenia and autism, where the prediction of situations in 
transition (like the chance to develop a mental disorder) and where 
development, environmental, genetic and epigenetic elements interact with 
each other. 
Economic benefit 
Furthermore, the results of the project, with the aim of altering the course of 
FMS, could be useful for the scientific community by providing a method, which 
is able to classify the characteristics underlying the sensitivity for the 
development of mental disorder comorbidities and psychological symptoms. 
Moreover, physicians should also be able to benefit by utilizing it as a basis for 
an individual medical treatment. It should also help in terms of obtaining more 
knowledge about how the disease runs it course, in terms of mental disorder 
risks and psychological symptoms, and hence, have a possible positive impact 
on the direct and indirect costs of FMS. 
Benefit for the patient  
First of all, through altering the course of the disease by mitigating the effects of 
psychological symptoms and mental disorder comorbidities related to FMS, or, 
in the best case scenario, completely preventing the development, the patients 
quality of life could be dramatically increased. 
In addition, another advantage is a system implementation, which is focused 
more on the patient. This element can help the patient to become more 
confident and stronger in dealing with a chronic condition that entails heavy 
economic and social consequences. 
Finally, it helps the physician to create a more personalized treatment, which 
can be adapted to the course of the patient’s disease. 
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2. Current status of medical database technologies and 
services 
This chapter gives an overview about already existing FMS patient databases 
and different medical database technology concepts, which could potentially be 
used for creating a medical patient database. There are already specific 
database technologies for collecting and storing medical patients’ data in such a 
way that they comply to data protection regulations. Since the FMS patient 
database should be created inside the European Union (EU) it seems 
reasonable to start analyzing medical projects and databases in the EU 
because they have to comply with the corresponding data and privacy 
protection regulations. 
In addition, open-source software platforms appear to be more beneficial not 
only because of economic reasons but also because they offer more flexibility in 
the design and additional creation of software modules. Further, when using 
proprietary database software one becomes dependent on third party software 
and also might be susceptible to changes in the terms of service. 
In the following, a range of database software and medical patient database 
projects will be described. 
2.1.Already existing FMS databases 
There are already a few FMS patient databases in place in the Hospital de 
Terrasa (CST), Spain and the University Hospital of Riga Stradins University 
(RSU), Latvia. At the moment these databases are very small. But they 
potentially could be used as a starting point to acquire an overview of the type 
of data that is stored for FMS patients. 
The CST database contains 150 FMS patients, of which 50 patients are in the 
control group. The database contains socio-demographic information (age, sex, 
education, premorbid intelligence and cognitive reserve), clinical and functional 
information (quality of life, sleep quality, emotional symptoms, physical 
impairment, psychosocial functional capacity, pain intensity), subjective 
cognitive complaints (memory and executive complain), cognitive assessment 
(attention and executive function), other psychological characteristics (stressful 
life events and personality traits) and pharmacological treatment as well as 
physical activity. [10] 
The RSU database contains information of 50 FMS patients that has been used 
to study neurological indicators, such as thermal quantitative testing, pain and 
other typical symptoms in FMS. The whole database test group had issues with 
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their memory recalling and over 80% of them where suffering from anxiety and 
depression. [10] 
2.2.Medical database technologies 
In the following section an overview of medical database technology concepts 
of Integrating Biology and the Bedside, Shared Health Research Information 
Network and the European Society for Immunodeficiencies are given. The focus 
hereby is on the technology used to create the databases. 
2.2.1.Integrating Biology and the Bedside (i2b2) 
Integrating Biology and the Bedside (from hereon called i2b2) is a National 
Center for Biomedical Computing located at Partners HealthCare System in 
Boston, Massachusetts and is funded by the NIH . It has been established in 6
2004 according to a Roadmap Initiative of the NIH. 
The i2b2 provides an open source scalable informatics platform for clinical 
researchers in the field of human health. One of the i2b2 core fields is the 
development and testing of new patterns in computation and methodologies for 
several diseases (type 2 diabetes mellitus, Huntington’s Diseases, airways 
disease, rheumatoid arthritis, multiple sclerosis, inflammatory bowels disease, 
major depressive disorder).  
Furthermore, the i2b2 Center supports a group of more than 250 academic 
users and “sponsors annual shared tasks for challenges in Natural Language 
Processing for Clinical Data”. [11] 
Next to the database software framework the i2b2 also provides a cooperative 
organizational infrastructure to help researchers in general to enhance the 
overall results and insights from their clinical studies. It provides a set of 
software packages to collect data but also to manage a clinical research project 
and run analysis with the data. 
Since i2b2 is an open source project the whole source code is available on 
GitHub (https://github.com/i2b2) and also, a development contribution to the 
project is possible. 
Figure 21 gives an overview about the available software modules from the i2b2 
framework. The i2b2 modules are structured into five different main groups of 
cells: The i2b2 Core Cell, the i2b2 Optional Cell, Workbench/Plug-in, Web Client 
and CRC-Plugin. A detailed explanation for each module as well as the i2b2 
 NIH stands for National Institutes of Health. It is the major United States government agency 6
for research in biomedical and public health.
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Workbench Client Software and complete Client & Server software packages 
are available on the i2b2 Foundation homepage . 7
!  
Figure 21: i2b2 available modules. 
The whole cluster of software modules (i2b2 “cells”) is also referred to as the 
i2b2 “hive”. It has some core components like the “i2b2 Core Cells”, which 
provide the main database core running on the server side. But the i2b2 hive is 
an extensible software architecture to which developers can add new cells 
(software modules), which functionalities are provided through plug-ins for the 
i2b2 Workbench and i2b2 Web interface. The communication between the 
Workbench and cells is realized through a web-service based on XML 
messages. This setup of the software architecture makes i2b2 very 
customizable and flexible for various kinds of clinical research projects. 
The Workbench is a compilation of the available client-side modules in form of 
Java plug-ins which can communicate with the other i2b2 cells and gives the 
user more possibilities in terms of analyzing, querying and displaying the data of 
the i2b2 hive in comparison to the web client. The Workbench is available as an 
executable for macOS or Windows operating system.[11] 
 https://www.i2b2.org/software/index.html , accessed August 7th, 20187
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The i2b2 user interface 
In the i2b2 web interface (Figure 22) the user can drag terms from an ontology  8
tree (top left) into a query tool (top right) where they can be used to create 
Boolean expressions to find the desired patients. The query tool is split into 
three panels, which are logically AND’ed with each other (logical conjunction). 
The items, which can be dragged into each panel, are logically OR’ed (logical 
disjunction) and can be negated by clicking onto the “exclude button”. This 
gives the user the possibility of creating complex Boolean algorithms to filter for 
the desired patient data. Furthermore, a minimum number of occurrences can 
be specified in a panel and a time range can be given. In the “previous queries” 
window (bottom left) results from earlier queries are saved and can be dragged 
into one of the panels to combine it with the current search.[11]  
All in all, this provides a very powerful tool to make detailed search requests 
even for users, which do not have any experience of data base programming 
and SQL queries. 
!  
Figure 22: i2b2 web interface. 
A very detailed user guide for the web client and desktop client can be found on 
the i2b2-community-website . 9
 In this context ontology mainly describes the grouping of medical symptoms or facts within a 8
hierarchy. They are subdivided according to differences and similarities.
 https://community.i2b2.org/wiki/display/mi2b2/mi2b2+User+Documentation , accessed 9
September 18th, 2018
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2.2.2.Shared Health Research Information Network (SHRINE) 
The Shared Health Research Information Network (SHRINE) is a general-
purpose clinical querying protocol that can be adapted to many different types 
of data repositories. 
The first prototype of SHRINE has been developed in 2008 together with 
different Institutional Review Boards (IRBs) of the three biggest health centers 
associated with Harvard University. These health centers allowed the usage of 
their data and the Harvard Medical School IRB approved to create a Query 
Aggregator Interface. This interface can send out requests concurrently to each 
hospital database and get an accumulated result of the number of matching 
patients. 
SHRINE enables collaborative research work across different institutions, which 
have independent database systems. While each institution maintains their own 
database with individual patient privacy regulations and access policies, 
different financial funding plans and own research teams, and so forth, SHRINE 
allows queries to all the databases in the network through a standardized web 
interface. 
The first SHRINE prototype was setup by Mr. Weber and his team. They faced 
complications with regulatory, political and technical issues during this process. 
One can assume that such issues might occur again while setting up another 
SHRINE system, hence the previous mentioned work could be used as a 
guideline, which highlights problems and their possible solutions. 
SHRINE was created with the success of i2b2 and SPIN  in mind. It should 10
allow researchers to analyze electronic health records of patients across 
independent platforms (initially it was the three participating Harvard hospitals 
for the prototype project). 
Due to the limited timeframe of only 6 months for the prototype project some 
exclusions had to be made:  
• Only the three largest databases of Harvard’s health centers were 
queried. 
• Limitation to only aggregate queries and a limited user group. 
• The query interface only allowed searching for the two parameters 
patients’ demographics and diagnosis. 
• The technical architecture of the prototype has to be redesigned to make 
it scalable for utilization with a large number of health centers. 
 The Shared Pathology Information Network (short SPIN) provides a solution for sharing data 10
between institutions over a peer-to-peer network while letting them keep autonomy over their 
data and protect the patients’ data privacy.
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SHRINE System 
The user interface for SHRINE is a web-based user interface very similar to the 
one of i2b2 (see Figure 23). Like the i2b2 interface the user can drag terms 
from an ontology tree (top left) into a query tool (top right) where they can be 
used to create Boolean expressions, as in the i2b2 interface. 
The query status window (in the prototype) shows the execution time of the 
query and the number of matching patients at each of the three hospitals, which 
have been part of the SHRINE prototype project. 
!  
Figure 23: SHRINE User Interface, similar to the web interface of i2b2. 
SHRINE architecture 
The main architecture of the prototype SHRINE is constructed by a Query 
Aggregator (hosted on servers of the Harvard Medical School) and SHRINE 
Adapters placed at every hospital.[12] 
The aggregator consists of the frontend web interface for the user access, the 
Query Entry Point (QEP) that is the point of entry for the SHRINE network and 
of the HUB. The QEP authenticates all incoming requests and later forwards 
them to the HUB for broadcasting. Furthermore, when it receives cumulative 
results back from the HUB it aggregates them into a single message for the 
client (web or desktop client). The high-level architecture of SHRINE is shown in 
Figure 25. 
The HUB broadcasts the requests from the QEP to the adapters and buffers the 
adapters responses before sending the collected results back to the QEP. 
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The SHRINE adapter is the point of 
entry for the database servers of the 
institutions. It converts the query into a 
format that is compatible with the 
format of the institution. In theory there 
is no limitation on how many databases 
can be added to the SHRINE network. 
Even though the adapters need to 
accept the standardized XML query 
format, the adapters backend can be 
modified without restrictions in order to 
connect it to a health centers database 
server utilizing a different technology. 
This gives flexibility of connecting 
different database technologies to the 
SHRINE network. 
2.2.3.E u r o p e a n S o c i e t y f o r 
Immunodeficiencies (ESID) 
ESID is a database for primary immunodeficiencies (PID). PID are rare 
diseases, therefore a cooperation between health institutions, also over national 
borders, is important to gather enough information for medical studies. ESID 
was originally founded in 1994. In 2004 a web-based ESID Online Database 
was developed by the Center for web-based Research and Patient Databases 
(CwebRD), a core facility of the IT Center of the University Hospital Freiburg, 
Germany.[13] 
The ESID Online Database is designed for data entry, reporting, data storage 
and the import of already existing data sources. All these features are available 
via a web interface (as shown in Figure 25), which is secured with login and 
password credentials. For a party to participate in the project an agreement 
must be signed with the ESID and an application has to be made to receive the 
login credentials. Without specific permissions each user only has access to its 
own patient data sets. To receive access for another party’s data set permission 
must be requested. Furthermore, if patient information is shared it can only be 
done in a de-identified manner.[14] 
In summary the database is custom build of components by the Java Platform 
family such as the Java Platform Enterprise Edition (J2EE) and the Java 
Database Connectivity interface JDBC™ for database access. The data is 
stored within a MaxDB™ SQL relational database management system.[13] 
Another central component is called the Enterprise Integration and 
Development Platform Application (EIDP). It is supposed to help with data 
protection, integrating solutions for clinical databases and to structure research 
Figure 24: High-level architecture of 
SHRINE.
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networks. The system is developed by the company Toolwerk GmbH. [13] Even 
though Toolwerk GmbH claim to be open source no access to the source code 
is give and it also seems that the ESID database has been their only project.
[15] 
!  
Figure 25: The ESID web platform for database access and patient entry. 
2.3.Medical Patient Database Projects 
In Europe as well as the United States, several projects and feasibility studies 
dealing with the topic of sharing and re-using Electronic Health Records (from 
hereon called EHRs) have already been conducted. Their main objective is to 
foster research and make existing EHR data available to a broader user group.  
This chapter will give an overview about the projects, which deemed most 
promising to be useful for the goal of this master thesis, on how to tackle the 
technical and possible economic challenges of creating a medical database. 
The Electronic Health Records for Clinical Research project, the Strategic 
Health IT Advanced Research Project and a German feasibility study for the 
usage of i2b2 will be explained briefly and their results analyzed. 
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2.3.1.Electronic Health Records for Clinical Research (EHR4CR) 
The Electronic Health Records for Clinical Research (EHR4CR) project was 
conducted over 4 years (2011 – 2014) with the goal of fostering clinical research 
on a European level by analyzing the possible re-use of already existing 
Electronic Health Records (EHR) at distributed locations. A total of 33 partners, 
coming from academia, pharmaceutical industry, as well as mid-size and small 
businesses, contributed to the project. 
During the EHR4CR project, a protocol feasibility platform was developed in 
order to send uniform query requests to databases across national borders. 
Furthermore, the feasibility protocol was evaluated in terms of fulfillment of 
necessary technical and governance requirements for a successful execution. 
The developed EHR4CR platform consists of three parts: 
• Workbench: Used to create the query criteria via drag-and-drop with a 
graphical user-interface based on a comprehensive query model.[16] 
• Orchestrator: Its function can be seen as the broker for the queries. It 
receives the queries from the workbench and knows where they should 
be redirected. It buffers the queries until the endpoint sends a request. 
• Endpoint: The connection point to the database. It polls for new queries 
on a regular basis and executes them to aggregate patients out of the 
anonymized patients’ data. Presently two types of Clinical Data 
Warehouses (CDW) are supported, the i2b2 and an own EHR4CR 
schema warehouse. 
Outcome 
Queries have been sent to different countries within the EU, therefore it was 
important to obey the data protection regulations in each country. Due to the 
right of ‘informational self-determination’ in Germany for example, the burden 
for re-use of patient data is substantially higher there. On the contrary, in the 
United Kingdom the creation of databases is quite easier, and the Clinical 
Practice Research Datalink represents the biggest collection of anonymized 
primary care patient data in the world, covering about 9% of the UK population, 
which makes up about 5.5 million people.[17] 
Despite all the obstacles, the EHR4CR project presented successfully that it is 
possible to use one software module, after some necessary modifications, in 
different hospital networks (in different countries) to collect aggregated 
information. It was possible to send one request to be executed at 11 different 
locations in 5 different countries. 
Next to the technical feasibility study the project also displayed that the legal 
obstacles can be tackled successfully but also should not be underestimated 
in terms of time management. 
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Finally, the EHR4CR project was conducted with a business model in mind of 
providing large sets of EHR data to medical research project in order to help 
them meeting their project deadlines in exchange for a usage fee. The EHR4CR 
project analyzed that most research projects in Europe are delayed because 
they cannot recruit or gather enough EHR data in their specified deadline, 
which cause major economic losses for them. 
2.3.2.Strategic Health IT Advanced Research Project (SHARP) 
The Strategic Health IT Advanced Research Project (SHARP) was established 
in 2010 by the Office of the National Coordinator for Health Information 
Technology, which belongs to the United States Department of Health and 
Human Services. 
It was created with the following objectives in mind: 
1. Receive data of EHR in different source formats. 
2. Process written text to create structured data. 
3. Utilization of common clinical models to create normalized EHR data. 
4. The data should be accessed and classified by a algorithm for the 
identification of cohort groups for a specific research purpose. 
Generally speaking it should help to standardize EHRs from different health 
care organizations and providers for secondary usage (e.g. by research 
institutes).[18] 
Comparing the SHARP with the EHR4CR project they are similar in the sense 
that both try to reuse EHR data. Whereas SHARP aims to store the anonymized 
patient data in a central location in contrast to EHR4CR that is storing the data 
only in distributed CDWs. Furthermore, SHARP applies Natural Language 
Processing (NPL) to extract information from clinical free text and create 
structured data whereas EHR4CR only relies on structured data as input. 
2.3.3.The German i2b2 experience 
A consortium of centers for medical information and medical university centers 
in Germany conducted a practical feasibility study about the usability of i2b2 to 
perform networked medical research in 2010. The general objective was to 
unlock existing patient information, which is collected in different databases on 
a routinely basis during primary care, for scientific research.[19] 
During the study, four different already existing medical databases were used 
for integration into an i2b2 database. The process & workflow of data migration 
into i2b2, the applicability and the performance of the i2b2 database were 
analyzed. The integrated databases had the following four database technology 
types: 
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• A CDW by Cognos BITM, IBM, at Erlangen University Hospital. The data 
has been converted from a star-based scheme into the ontology format 
of i2b2.  
• A documentation about prostate cancer in the Electronic Medical Record 
system by SoarianTM , Siemens Inc. at the Erlangen University Hospital. 
• A local electronic data capturing system, which metadata has been 
transferred manually into a Microsoft ExcelTM spreadsheet and later per 
script-based conversion into the ontology format of i2b2. 
• A trial database (Competence Network for Congenital Heart Defects) 
using the electronic data capturing tool SecuTrialTM (iAS GmbH). Data 
has been exported and transformed into SQL statements with a 
specifically developed tool (Java), which are compatible for the import 
into i2b2. 
For de-identification of patient data, if necessary, the pseudonymization service 
for medical research data[20], [21] provided by the German Technology and 
Method Platform for Networked Medical Research (TMF) has been used. 
Furthermore, a tool for the setup and administration has been developed to 
make the installation of i2b2 onto a virtual machine from source code faster and 
simpler as well as to help with the whole process of setting up and loading an 
i2b2 database. The tool has been published on the TMF website and the i2b2 
Academic User Group  to make it available to be used by the public. Further 11
research yielded that the original setup and administration tool has been 
developed further and was integrated into a project called the Integrated Data 
Repository Toolkit (IDRT).[22] IDRT entails an i2b2 installation wizard, a GUI 
based IDRT-Import-Tool to start the ETL  process and a GUI based i2b2-12
Ontology-Editor to implement own terminologies. The IDRT-Import-Tool allows 
the import of data from standard formats, such as CSV, CDISC ODM  and SQL 13
databases, into i2b2. 
Since 2015 IDRT is available in the English language as well and the 
installation wizard can be downloaded on the IDRT homepage . 14
A more detailed description of the used hardware and software tools can be 
found in the case report of the study. [19] 
Conclusion 
 https://community.i2b2.org/wiki/display/i2b2wizard/Home , accessed June 20th, 201811
 ETL stands for Extraction, Transformation and Loading. First information is extracted from a 12
data source, after the data is transformed into the data format of the target system (e.g. i2b2) 
and later loaded into the target database.
 CDISC ODM stands for Clinical Data Interchange Standards Consortium Operational Data 13
Model and provides a platform-independent global standard for medical data.
 http://idrt.imise.uni-leipzig.de/IDRT-II/#Contact , accessed June 29th, 201814
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The study demonstrated that i2b2 is a feasible tool to enhance networked 
medical research. Implementation of the TMF privacy related tools was possible 
without problems or reduced performance. Therefore, all privacy guidelines 
could be fulfilled for the usage of i2b2. 
Compared to native SQL queries i2b2 had a lower reaction time but offers 
advantages in terms of an easy to use GUI to create queries for medical users 
without detailed knowledge in database structures. 
2.4.Summary 
The presented projects and database technologies demonstrated that a 
successful setup of a medical databases for EHRs is a viable task. Technical as 
well as legal obstacles can be solved. Furthermore, the EHR4CR project also 
gave a guideline in terms of how to build a business concept for such a medical 
database. 
The extensive literature research showed that a common denominator in a lot of 
projects within the EU is the support or usage of the database system i2b2. The 
aforementioned TMF fosters the dissemination of i2b2 and is cooperating with 
the i2b2 community. 
Furthermore, next to the technical challenges the legal obstacles in terms of 
privacy regulations that can be different in each country should also be taken 
into consideration because they are also very important in order to setup a 
database with sensitive patient information. 
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3. Technical feasibility 
In this chapter a technical feasibility analysis of creating a database for FMS 
patient data is performed. As a guideline regarding the technical requirements 
for such a database the aforementioned research consortium with the aim of 
altering the course of FMS and ideas from EHR4CR will be applied to the use 
case of a FMS patient database. 
First the technical system requirements for the input and collection process of 
patient data as well as the requirements to the system for data access and 
utilization of analysis methods and tools in the field of FMS are be laid out. 
Based on the defined system requirements an initial project proposal will be 
given, utilizing the available database technologies mentioned in the previous 
chapter. The practicability with existing software and the necessity of additional 
development to reach the system requirements targets are analyzed. 
3.1.System Requirements 
In order to be useful for FMS research, the database system needs to fulfill and 
support a data collection process that is feasible for medical practitioners in 
primary care. Hence, it should be easy to use for the patient as well as for the 
medical practitioner. Further, typical analysis methods in the field of the FMS 
research should be supported to create additional value. 
3.1.1.Data acquisition requirements 
According to the aforementioned research consortium proposal [10] with the 
aim of altering the course of FMS a group of 80 patients should be used in 
order to create an improved mathematical model with a Monte Carlo Analysis. 
These 80 patients as well as the already existing patient data at CST (150) and 
RSU (50) should be integrated into a database and used for validation of the 
previously created mathematical model. 
The database system should follow the international health data standard HL7 
Fast Healthcare Interoperability Resources (FHIR). This standard defines the 
exchange of EHR in terms of an Application Programming Interface (API) as 
well as data format and elements. Furthermore, the database should be 
accessible for software to perform and apply the Monte Carlo mathematical 
model. 
The data entry of EHRs should be done via a mobile application. Patient data 
needs to be saved anonymous and according to the data protection regulations 
in the participating countries and the EU. Data entry should be possible in two 
ways: 
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• Via the patient by answering a questionnaire in order to generate the 
psychological variables for the database. 
• Via the clinical practitioner through a special interface to enter patient 
data. 
Furthermore, a mathematical mode should be integrated into the database in 
such a way that it fills in missing patient variables that could not have been 
recorded during the survey or by the doctor. This mathematical model should be 
derived from a Monte Carlo Analysis on a verified patient set. 
This is because each practitioner can only assess aspects corresponding to his 
field. By adding simulated variable entries, every patient will be completely 
defined. Therefore, most patients will consist of a combination of real and 
simulated variables. Simulated variables should be clearly marked and 
assigned with an uncertainty rating. 
In Figure 31 a schematic flowchart of the desired patient data input process into 
the i2b2 database is shown. 
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Figure 31: Required patient input process to the database. 
3.1.2.Data analysis requirements for the database 
The data analysis goal for the FMS patient data is to stratify the patients into 
different subgroups depending on their symptoms evaluated in the database. 
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A study conducted in 2008 [23] used a clinical tool, called the Fibromyalgia 
Impact Questionnaire (FIQ), to stratify patients into two subgroups, because 
these groups were fitting their data profile the best:  
• FM-Type I: Patients having the lowest levels of anxiety, depressive and 
morning tiredness symptoms. 
• FM-Type II: Patients characterized by higher levels of fatigue, morning 
tiredness, anxiety, etc. 
The FMS is a heterogeneous disease with a variation of symptoms and their 
intensity for each patient. According to this study the FIQ represents a good tool 
to assess a high number of clinical characteristics related to the FMS. The study 
has been conducted on two different days separated by two weeks between 
each other. 
The first day was a one-hour interview to obtain demographic information, 
identification of FMS characteristics and principal complaints, etc. 
The second day was used to evaluate the patients cold pain sensitivity and to 
field out several questionnaires. 
By using this study as an example for the analysis and stratification of FMS 
patients one can derive a set of requirements the database has to fulfill: Either 
the database itself has to contain the corresponding analysis tools or it needs to 
give the ability to export the data for utilization of further analysis tools, which 
are necessary. Therefore, this chapter will also analyze the capability of i2b2 for 
patient data analysis and stratification. 
3.2.Project Proposal with i2b2 
In this section, a project proposal and its feasibility analysis on a technical level 
for the utilization of the i2b2 software to create a database of EHRs for FMS 
patients will be done. In the previous section, mentioned system requirements 
will be taken into consideration. Since i2b2 already offers a great variety of 
available software modules for clinical research it will be analyzed to what 
extent “out-of-the-box” software modules can be used to fulfill the requirements 
and which additional software modules have to be developed in order to meet 
the project requirements. 
3.2.1.System Architecture 
The primary proposal is to create an i2b2 database server at the locations 
already having a set of FMS patients, such as CST and RSU. The i2b2 server 
can be installed on a virtual machine with a Linux distribution supported by the 
i2b2 Wizard (recommended is Ubuntu 14.04 (32 bit)). The i2b2 Wizard, of the 
IDRT, offers a simplified way to install the i2b2 server. The different server 
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locations should be connected utilizing SHRINE to give all participants access 
to the complete EHRs. 
An alternative proposal is to create an i2b2 database server at one central 
location that has to be chosen beforehand and to which all research participants 
have access to and are also willing to save the patient data at. 
From a technical and financial perspective, a central server solutions has more 
advantages. Hence, it seems more reasonable to proceed with this approach. 
In addition SHRINE networks (in the USA and Europe) so far only have been 
used within national borders[24]. The previously described ESID project can be 
used as an example for a centralized database. Their servers are located at the 
IT department of the University Hospital in Freiburg, Germany. 
Last but not least, an expansion with SHRINE can be realized at a later time 
after more experience has been gained and the database would start to grow at 
a fast pace. 
3.2.2.Database Input 
The initial content for the database can come from the integration of the patient 
data at CST and RSU. The data needs to be analyzed and converted into the 
Pros Cons
An advantage of this approach would 
be that each participating entity keeps 
the property rights and the data in its 
own designated location. This could 
potentially simplify obstacles of 
different data privacy regulations of 
different countries within the EU. In 
addition, a distributed architecture can 
help to distribute the server load for a 
growing database in the future. 
As a disadvantage could be seen 
that this approach has a more 
complex technical architecture and 
that it could be more expensive in 
terms of maintenance and additional 
hardware that is needed to establish 
several server locations. 
Pros Cons
Compared to the first proposal an 
advantage could be a simpler and 
more cost-effective solution in terms 
of maintenance and hardware, 
because less servers and no SHRINE 
architecture are needed.
A disadvantage could be more 
possible obstacles regarding data 
protection regulations and less 
scalability for a growing patient 
database. 
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ontology format of i2b2. Several ETL tools, such as the previously mentioned 
IDRT-Import-Tool, are already available to help with the automation of the 
import process. Furthermore, i2b2 as well as SHARP offer natural language 
processing functionalities. This can be beneficial for the integration of EHR or 
questionnaires that are not available in a structured data format or only exist in 
analogue. Some of the databases, which have been mentioned in the previous 
chapter, successfully managed a complete import of other databases and 
different data formats into i2b2.[19] 
The main source of FMS patient data should be the ongoing input of data 
during primary care. Ideally through answering of questionnaires from the 
patient itself or through the medical practitioner via a special interface. 
Therefore, an interface for the practitioner and the patient needs to be created. 
The first step is the creation of a web-interface with a mobile version to make it 
accessible for tablets and smartphones. The next step is the creation of a 
mobile App to function as the database interface. 
The patient interface needs to guide the patient through the answering process 
of the questionnaire and generate data variables from the answers. After that 
the patient profile will be analyzed and for missing variables simulated data will 
be derived from the Monte Carlo Mathematical Model. Simulated data has to be 
marked as such. Further, the patient data has to be pseudonymized according 
to EU legal privacy standards before imported to the database. For this purpose 
the pseudonymization service for medical research data[20], [21] provided by 
TMF can be used. The compliance of this service with the new GDPR 
regulation (which are applicable since May 25th 2018) needs to be checked. 
Furthermore, the interface for the medical practitioner needs to allow him or her 
to create new patient and to modify the patient variables directly. 
A straightforward approach to create a data input interface would be to tap into 
already existing Electronic Data Capture (EDC) tools. Such an EDC system, 
which has a worldwide user community in medical research is REDCap 
(Research Electronic Data Capture). The Vanderbilt University has done the 
original development and rollout. A big international community of non-profit 
organizations now supports it. The REDCap software is free of charge for non-
commercial research purposes.[25] 
REDCap User Interface 
The REDCap software can be used to create online surveys and databases 
without having extensive technical knowledge. In REDCap the user can create 
projects. A project is a website used for the entry of data. The tool is suitable for 
almost any type of data and a multitude of purposes, because the user can 
create each survey for the data entry individually and therefore REDCap offers 
a lot of flexibility. 
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Under the “Project Setup” Tab the user can build his or her own survey that can 
contain the following formats: 
• Text and notes boxes for alphanumeric text, which optionally can use 
validation to ensure a specific input format, such as a date for a birthday. 
• Calculated fields that are automatically filled based on a predefined 
formula and another data field. 
• Multiple choice and checkbox fields to select from a set of answers. 
• Branching logic can hide or reveal fields based on previous answers. 
A data record (e.g. information about a patient) can be constructed of several 
input questionnaire forms. For organizational reasons the status of each form 
can be marked as complete, unverified, incomplete and incomplete (no data 
saved. This helps to get a quick overview whether information in certain forms 
are still missing. 
Furthermore, REDCap offers an export functionality for a variety of formats: 
CSV (raw data or with labels), CDISC ODM (XML), SPSS Statistical Software, 
SAS Statistical Software, R Statistical Software and Stata Statistical Software. 
REDCap offers many useful features to support the data collection process 
throughout a project. The REDCap project homepage has many detailed 
explanatory videos  regarding its functionality and after joining the REDCap 15
consortium one can profit from the support of a big REDCap community.[25] 
REDCap Infrastructure Requirements 
Regarding computing power, memory and hard drive space REDCap does not 
have any specific requirements but it recommends 10 GB free disk space on 
both the web server and the database server. REDCap is supported on different 
operating systems (Linux, Unix, Windows, Mac). Furthermore a smtp webserver 
is needed to send emails from REDCap and an optional fileserver for the 
storage of files uploaded to REDCap. 
On the REDCap project homepage, a detailed documentation about the 
technical overview and requirements is given.[26] 
3.2.3.Data Analysis 
The primary i2b2 web-client and workbench interface that have been presented 
in chapter 2.2.1 offer the capability of aggregating a patient cohort group for a 
further study. This gives the user the possibility to filter patients based on 
desired symptoms or other available features. 
As an example, if a researcher is looking for a patient group that has mental 
and behavioral disorders and/or a defect with its nervous system and is older 
than 34 years. 
 https://projectredcap.org/resources/videos/ , accessed August 17th, 201815
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To find this patient group, the web client will be utilized: The ontology tree of the 
i2b2 demo version  of the web client has diseases categorized according to 16
ICD10 , which makes the search easier because it is following a standardized 17
scheme. Within ICD10 diseases and symptoms are categorized by letters and 
numbers, hence the researcher can select from an alphabetically and 
numerically ordered list. ICD10 is only an example of a standardized and 
international classification format in i2b2. A variety of different classifications are 
already available in the ontology tree of i2b2 and the user can create individual 
ontologies (e.g. for FMS symptoms). In the case of FMS for example one might 
want to classify the patient by FM-Type I or FM-Type II with a specifically 
created ontology for this use case. Such new classifications can be used to 
perform further analysis or to do more specific grouping of the patients. 
In the specific case of the mentioned example the ontologies “Diseases of the 
nervous system (g00-g99)” and “Mental and behavioral disorders (f01-f99) are 
selected in the first group (left column). One or more of the selected ontologies 
must be present in the patient. The second group (middle column) excludes 
patients with an age between 0 and 34, therefore the selected patients have to 
be minimum 35 years of age. The third group (right column) is left empty for this 
query, but additional parameters could be added here. The constructed query is 
shown in Figure 32. 
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Figure 32: Query for patients with mental diseases and/or mental and 
behavioral disorders and more than 34 years of age. 
After executing the query, the obtained results can be seen in Figure 33. In the 
i2b2 demo database 74 patients with the specified query parameters were 
found. Furthermore, we can see an age distribution and the breakdown into the 
 https://www.i2b2.org/webclient/ , accessed August 5th, 201816
 ICD10 stands for International Statistical Classification of Diseases and Related Health 17
Problems and is the most important and worldwide recognized classification system for medical 
diagnosis published by the WHO. It gets updated on a regular basis.
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top 20-diagnosis of the patients. It is possible to choose a variety of additional 
query results types, such as “Top 20 diagnosis breakdown” or “Length of stay 
breakdown” just to name a few. A very detailed explanation of the query 
generator is available directly in the web client under the button “help” in the top 
right corner. Hence going here into more detail would exceed the scope of this 
thesis. 
!  
Figure 33: Patient cohort results with age and top 20-diagnosis breakdown. 
The standard web-client already offers some analysis tools for simple patient 
analysis with de-identified data. To obtain more detailed and identified patient 
level data other existing medical databases, such as the one at the UMass 
Medical School, implemented a process to create an access request that has to 
be approved by the Institutional Review Board (IRB).[27] 
To enhance the client’s capabilities additional tools can be installed into the web 
client as plugins. Within the i2b2 community  several community projects are 18
available to extend to capability of workbench and web client. 
i2b2/tranSMART 
Another useful extension is i2b2/tranSMART . It is an application layer for i2b2, 19
which allows the same functionality as i2b2 plus the capability to perform 
complex statistical analysis and loading data from a simple excel sheet or other 
different sources into the database.  
 https://community.i2b2.org/wiki/ , accessed August 6th, 201818
 http://transmartfoundation.org , accessed July 10th, 201819
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The Global Rare Diseases Patient Registry Data Repository by the NIHs 
National Center for Advancing Translational Sciences (NCATS) in conjunction 
with the Harvard Medical Schools department for Biomedical Informatics uses 
i2b2/tranSMART. They structured the access rights into a two-level approach: 
• Level 1 access: Only provides aggregated data with no IRB approval 
required. 
• Level 2 access: Provides full patient level data but needs a user with IRB 
approval. 
Furthermore, the Harvard Medical School provides a demo version  of i2b2/20
tranSMART (with level 1 data access) to get acquainted with the user interface 
and some of its analytic capabilities. This database is created from the National 
Health and Nutrition Examination Survey (from hereon NHANES) with around 
41,000 patients and around 2,000 environmental patient level variables.[28] 
The user interface of i2b2/tranSMART is similar to the one of i2b2. As shown in 
Figure 34 an ontology tree is present on the left side. On the right-side patient 
subsets can be created. 
In the following usage example of i2b2/tranSMART the goal is to check the 
hypothesis that there is a correlation of patients that are smoking and therefore 
are more likely to have been diagnosed with cancer. As a starting point two 
subsets filtering for the diagnosis (cancer) are created. For subset 1 “any 
cancer”, “blood cancer” and “leukemia” are selected. For subset 2 “lung cancer” 
and “mouth cancer” are selected. 
First one needs to drag the desired terms from the ontology tree on the left into 
subset 1 and subset 2 on the right side. Equivalent to the i2b2 query creator the 
terms in one box are logically OR’ed with each other and the boxes logically 
ANDed (as highlighted in Figure 34). After the desired terms have been 
selected clicking the “Generate Summary” button can start the patient 
aggregation process. 
 https://nhanes.hms.harvard.edu/transmart , accessed July 10th, 201820
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Figure 34: i2b2/TranSMART subset selection. 
A summary statistic can be seen in the “Results/Analysis” tab (Figure 35). In the 
summary a histogram and comparison of the patients age of both subsets, a 
gender distribution, as well as a race distribution are given.  
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Figure 35: Results/Analysis tab with Summary Statistics 
 
Since the goal is to analyze the association of cancer 
with the smoking behavior of the patients the term 
“Current Cigarette Smoker?” from the ontology tree 
(Figure 36) can be moved per drag & drop into the 
“Results/Analysis” tab.  
After the smoking behavior term has been dropped 
into the Summary Statistics, the association will be 
calculated. The result (as shown in Figure 37) is a 
new bar graph for each subset displaying the 
association with the current smoking status. One can 
see that for patients diagnosed with both types of 
cancer the share of patients that are currently 
smoking is higher. Furthermore, one can see that the 
result is marked as significant at a 95% confidence level. 
Figure 36: Smoking 
behavior.
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Figure 37: Association of current smoking behavior with cancer diagnosis. 
This demonstration is just a simple analysis with a limited demo database and 
only level-1 access rights. But nevertheless, it demonstrates in a good way how 
i2b2/tranSMART works and can be used to create a patient group and initial 
hypothesis for a more detailed analysis. 
To perform a deeper analysis more detailed patient level data is necessary 
(level-2 access in the case of NCATS) to make use of more powerful statistical 
tools such as the R software tool. The group of Chirag Patel at the 
Bioinformatics Department at the Harvard Medical School gives a hands-on 
step-by-step explanation for the utilization of the R software tool for medical 
analysis of the NHANES patient level data.[29] 
Furthermore, there are plugins already available for i2b2, such as GIRI  that 21
offer a generic integration of the statistical R software directly into i2b2. GIRIs 
approach is to make the integration of one or more desired add-on 
functionalities (also called “scriptlet”) as simple as adding a R script and an 
optional XML configuration.[30] The GIRI developers aim was to simplify the 
usage of R within i2b2 as compared to other available solutions (“R Engine 
Cell”  and “rgate HERON/i2b2” ) 22 23
If functionalities that are important for FMS database are not already available 
in the community, there is always the possibility of creating a new i2b2 hive cell 
suiting the specific use case. 
After analysis of a multitude of projects performed on i2b2, thorough utilization 
of the available demo client and examination of the user guides it can be 
concluded that i2b2 offers a good basis for the EHR data analysis of FMS 
 https://community.i2b2.org/wiki/display/GIRI/GIRI+Home , accessed July 12th, 201821
 https://code.google.com/archive/p/i2b2-r-engine-project/ , accessed July 12th, 201822
 https://informatics.kumc.edu/work/wiki/HeronStatsPlugins , accessed July 12th, 201823
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patients. An initial cohort analysis with aggregated patient data can be 
performed directly in the software and for further analysis with external tools the 
data can be exported after an approval is granted. 
Overall i2b2 seems to offer the capabilities to perform similar studies to the one 
performed by De Souza et al. [23] for the grouping of FMS patients. 
Furthermore, i2b2 offers the possibility to enhance collaborative research by 
allowing other researchers to make a cohort analysis for their studies but it also 
ensures the patients privacy by only displaying aggregated data without further 
approval. 
3.3.Next Steps and Summary 
An analysis of the tools i2b2, the i2b2 add-on i2b2/TranSMART and REDCap 
resulted in the following:  
i2b2 is great tool to foster collaboration and sharing of information between 
different medical centers. It lets the researcher do initial research to allocate a 
patient cohort group that fits its desired criteria in a simple and privacy conform 
way. Furthermore, with the right tools (which are available within the i2b2 
community) data from various sources can be integrated. In general, i2b2 has a 
big open source community that already offers a big variety of additional 
software tools and packages. One being i2b2/TranSMART, which offers more 
complex analysis capabilities to create an initial hypothesis. 
Nevertheless, i2b2 does not seem suitable for the collection of patient data with 
questionnaires on a regular basis during patient visits. For this the REDCap tool 
seems more suitable. It has been specifically developed for the purpose of 
patient data collection. REDCap can be used to create and schedule individual 
online surveys. Those surveys can either be filled out during the patient visit on 
a tablet/computer or at home by access through a link. 
Therefore, the next steps are for one to obtain a license for REDCap to install 
an instance on a server to proceed with the creation of FMS specific surveys. 
The other one is to create an i2b2 installation to import the data from the 
REDCap surveys and already available FMS patient data. 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4. Business feasibility 
In this chapter the business feasibility of a FMS EHR database is conducted. 
This entails an evaluation of the legal feasibility as well as an expense 
estimation and possibilities for income generation. 
First the legal obstacles in terms of data protection regulations in the EU 
(especially the GDPR) are analyzed. Further the cost for necessary investments 
for server hardware and expert knowledge (IT and legal) for the setup and 
maintenance of a medical database are analyzed. Last but not least a 
possibility for income generation with a cost and profitability analysis is 
performed. 
4.1.Legal feasibility 
Another very important step in the process of a database setup that collects 
personal information of individuals is to be aware and adhere to the legal 
obligations and data protection regulations of the countries it will collect data in. 
Of specific importance within the EU is the GDPR, which is a regulation in the 
EU for data protection and privacy for individuals residing in the EU. 
The regulation has been enforced on May 24th, 2016 and is applicable in the 
member states since May 25th, 2018. 
Overview of the GDPR:  
The following paragraphs shall give an overview about the GDPR and comprise 
a summary of the GDPR that deemed most important for the context of this 
thesis. A detailed overview of the GDPR can be found on the website of the 
European Commission . 24
A company needs to apply to the GDPR if the core business is the processing 
of personal information of EU residents, regardless whether the processing is 
done inside or outside of the EU. Furthermore, it is irrelevant whether the 
service charges a fee or is offered for free.[31] 
The conditions for consent of the user have been strengthened. A request for 
the consent must be made in an understandable and easily accessible form. 
Clear and simple language shall be used, and it shall be distinguishable from 
other matters. Furthermore, it must be as simple to withdraw as to give the 
consent.[32] 
 https://ec.europa.eu/commission/priorities/justice-and-fundamental-rights/data-protection/24
2018-reform-eu-data-protection-rules_en , accessed August 12th, 2018 
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A specific purpose for the collected data has to be given for what and why this 
specific data is collected. It is only allowed to use the data for this specific 
purpose. The data shall not be stored longer that it is necessary. Technical and 
organizational measures have to put in place to ensure the security of personal 
data.[33] 
A company needs to assign a Data Protection Officer (DPO) if its main business 
involves the monitoring of individuals in a large scale, regular and systematic 
manner. The DPO can be employed by the organization itself or contracted 
externally. For example, a DPO is necessary in a hospital processing large 
sets of sensitive data.[34] 
For scientific research, the GDPR offers some simplifications regarding to how 
specifically and granular the consent must be given. When researchers are not 
able to completely identify all the purposes for the data processing, individuals 
can be asked to consent to research projects or certain scientific research 
fields.[35] 
Impact on this project: 
First, after consulting the GDPR it becomes evident that a database project 
collecting health data of individuals on a regular basis needs to take the GDPR 
into consideration and follow its regulations. For the purpose of scientific 
research some simplifications have been made in terms of obtaining consent 
from the patient.  
Nevertheless, the GDPR puts an additional burden for the successful 
accomplishment of a FMS patient database project. An external consultant, 
such as a lawyer, should be used for reference to make sure that the database 
project is setup in a GDPR compliant manner. Last but not least most likely a 
DPO has to be hired or at least externally contracted for the purpose of this 
project. 
This means that for such a small project extra costs due to legal counseling are 
created for the initial setup and most likely also on a regular basis in form a 
permanent legal advice through a DPO. 
4.2.Expenses 
First of all, a very important point for a successful database setup is reliable 
server hardware to install the necessary software. In this case that means the 
REDCap database and the i2b2 database software. The recommendation is to 
have different servers or at least different virtual machines for the different 
platforms. 
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Initial test installations showed that one powerful server should be sufficient to 
host several virtual Docker  containers for the REDCap and the i2b2 25
installation. By using Docker containers, the physical hardware can be utilized 
in a more efficient way compared to renting several virtual private servers 
(VPS). 
For the search of a standard VPS a few minimum requirements (100GB 
storage, 8GB RAM, 4 CPU vCores and backup functionality) have been set to 
make the comparison of different providers easier  
A comparison of different service providers yielded a VPS that meets the 
minimum requirements are in the range of 5€ - 12€ per month. Most providers 
have bigger VPS packages available, which should be taken into consideration 
to be prepared for an expansion of the database. 
Hence the biggest cost factor will be the staff, which needs to be hired for the 
setup and maintenance of the database. The experience during the feasibility 
study showed that additional time for the database setup should be taken into 
consideration in order to account for unexpected obstacles. An initial and 
completely running system setup (including REDCap and i2b2 database) could 
be expected within a 3 to 6 month timeframe done by a system administrator 
working fulltime. The system administrator should ideally have knowledge with 
database systems and server security. After the initial setup the maintenance 
effort should decrease, depending on the customer needs. 
Next to the system administrator a legal counselor for the role of DPO is 
needed. Most likely during the initial setup phase higher workload is expected 
for legal counseling but should reduce after that. There the most reasonable 
decision is to hire external legal counselor for the setup phase and reduce is to 
an on demand basis afterwards. The DPO needs to have expert knowledge 
about data protection law and additionally understand the IT infrastructure and 
technology to ensure its regulatory compliance. As explained in the previous 
subchapter according to the GDPR regulations it is necessary for a company 
that processes patient data to appoint a DPO. 
A system administrator should be hired full time to take care of system 
maintenance, data import and customer requests. To support in the initial setup 
phase of the database and to ensure that a functioning import routine from 
REDCap to i2b2 can be implemented an IT expert on SQL databases should be 
contracted for a 6-month period (assuming a cost of 20 000 €). For the system 
admin we assume a cost of 30 000 € annually. Since the GDPR just came into 
place in March 2018 it is hard to estimate the workload, but it should be less 
than a half time position. Assuming 35 000 € for a legal expert and the need of 
his consultation for 1/5 out of the year (which roughly would be 8 hours per 
week) it would amount to 7 000 € for external legal consultation. 
 Docker is software that virtualizes applications to create several instances of an operating 25
(called containers) isolated from each other sharing the same resources on the same host 
system. https://www.docker.com/ , accessed September 18th, 2018
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Necessary hardware (computer, cellphone, etc.) and office space is only 
considered for the system administrator who would work full time, at a rate of 
1200 € annually. For the external IT expert and DPO a bit higher fee is assumed 
for working out of their own premises. A co-working space  in Barcelona can be 26
rented from as low as 150 € monthly including all costs and amenities such as 
Internet, meeting rooms, etc. 
In the second year only, the system admin and the extern DPO will work and in 
the third year one (or more) additional system administrator(s) should be hired 
depending on the amount of work and customers.  
The in Table 1 presented expenses shall only demonstrate the bare minimum 
expected for running such as database service. Additional 10 000 € to 20 000 € 
should be added for the firsts year to accommodate possible marketing or 
travelling expenses. 
Table 1: Minimum expenses to run a medical database platform. 
4.3.Incomes 
In order to generate incomes, two different business models seem possible: 
The first business model is the provision a complete service line for a data 
collection and storage concept for EHRs. This includes the REDcap tool for 
survey creation and data collection on a routine basis as well as the import of 
this collected data and already existing data (at the hospital or research 
organization) into the i2b2 database. To each customer a personal account shall 
be given, which only allows him the full access to his EHRs. Since i2b2 shall 
foster the research and identification of cohort patient groups for medical 
research, it shall be possible to receive aggregated patient counts for 
characteristics through the i2b2 search interface. Full access to the data shall 
Years Year 1 Year 2 Year 3
Expense statement
Staff € 57000 € 37000 € 67000
Co-working space € 1800 € 1800 € 3600
Office supplies € 1200 € 1200 € 2400
Safety buffer € 10000 € 15000 € 20000
Tota l opera t ing 
expenses
€ 70000 € 55000 € 93000
 https://www.lavacacoworking.com/ , accessed September 20th, 201826
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only be given if the owner authorizes the access (following all legal 
requirements). 
Furthermore, with this concept the EHR data will be stored in a central location. 
This approach has the advantage of saving cost and effort in terms of 
maintenance of the server and database systems by implementing a scalable 
system. Ideally the service cost per customer should decrease the more 
customers join the platform. Furthermore, the customers can benefit from a 
growing number of EHRs they can use for their own research similar to the 
ESID (Ch. 2.2.3) and EHR4CR (Ch. 2.3.1) projects described before. For some 
diseases such as FMS it is very hard and costly to find sufficient patient data for 
a research project. 
Disadvantages 
Scaling of the database only works if there are enough customers to share the 
resources with. Moreover, some customers could have doubts about storing 
privacy sensitive data in an external database. Applying all necessary security 
and privacy measures necessary can mitigate this doubt to give the customer 
enough confidence about the security of the database service. 
The second business model could lay in the provision of consulting services 
for the setup of medical databases on the customer’s premises. Actually, the 
first and second models do not have to exclude each other. If a customer does 
not want to outsource its patient data to an external provider, consulting 
services can be delivered for the database setup to provide an individual 
solution adapted to the customer needs with a regular care and support plan. 
The main advantage of the second model for the customer is to have full 
control about the data residing in its own hardware. Another advantage could be 
the possibility to modify the database specifically for individual needs of the 
customer. 
Nevertheless, this model has disadvantage in terms of gathering patient data 
for research and fostering the collaborative research work between different 
institutions. Furthermore, additional staff would be needed to accommodate for 
the necessary consulting servers and is hard to estimate at this moment. 
Revenue generation 
The estimated minimum cost to setup and maintain the database service are 
around 70 000 € for the first year. If one would start with 10 hospitals the shared 
costs would be 7000 € per institution annually to maintain the service. To obtain 
more customers, the goal is to offer a lower price and try to share the cost 
between more customers. Studies in this thesis showed that patient databases 
could store data for several hundred thousand patients and several million 
records in some cases. The Hospital de Terrasa and the University Hospital of 
Riga Stradins University only hold around 50 to 200 patients at the moment. 
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Assuming 100 to 300 patients per institution it seems possible to accommodate 
up to 1000 institutions with one database, by simplifying and not taking the 
server load and usage profile into account. 
The estimation is to start out with 10 institutions in the first year and the aim of 
serving 25 institutions in the second year and 50 institutions within 3 years. 
Assuming that one can acquire the aforementioned amount of institutions and 
that the institutions are willing to pay a usage fee of 2 500 € annually a 
breakeven point could be reached in the second year if the workload can be 
handled by one system admin in the first and second year. By the third year an 
additional system admin would be hired. The expected income statement is 
shown in Table 2. 
Table 2: Expected income statement for the first 3 years. 
Without a thorough business plan, which would include a more detailed market 
analysis it is hard to estimate how many research institutions and hospitals 
would participate in such a database and what amount they would be willing to 
contribute. As explained in the previous chapters gathering a big enough cohort 
group for a study most of the time requires a great effort and financial 
resources. Having access to a big database could dramatically reduce this effort 
and therefore save costs. Hence it can be assumed be assumed that research 
institutions and maybe even pharmaceutical companies would be willing to pay 
for such a service (as mentioned in 2.3.1 by the EHR4CR project). 
Due to the time constraints of this thesis a complete business plan cannot be 
performed, and simplified estimations are made. 
Year 1 Year 2 Year 3
Income statement
Net sales € 25 000 € 62 500 € 125 000
Expense statements € 
Operational expenses € 70 000 € 55 000 € 93 000
Net income - € 45 000 € 7 500 € 32 000
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5. A use case with REDCap and i2b2 
This chapter describes a use case of how patient data could be collected via 
surveys created through REDCap for a regular patient visit and later stored in 
i2b2. Entities with access to the database can run anonymous queries with their 
personal criteria to search for a patient cohort for their potential studies. If a 
cohort has been identified a patient data set can be exported. 
5.1.Data collection with REDCap 
As the license for REDCap for UPC is in progress, a trial version is used that 
has the full functionality but is limited to a time period of one week. 
To simplify the use case a simple survey has been used to gather the contact 
and basic information about a patient (as shown in Figure 51). Two sample 
patients have been created to show an exemplary import to i2b2. 
!  
Figure 51: Basic patient information survey with REDCap. 
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The collected information can be viewed inside the REDCap web based user 
interface (see Figure 52) and exported to a CSV based file. 
!  
Figure 52: Example view of 2 patients in REDCap. 
To start the data collection links to the survey can be send to the patient to fill 
them out at home or they could be using a tablet or computer while in the 
doctors office to fill out the survey. The information is collected anonymously 
unless it is asked for personal information. This use case contains fields for 
personal information and email address. If necessary, these fields can be left 
out and the patient can only be identified by a patient number. In the ESID 
database for example the patients personal information are not stored in the 
database and only the practicing doctor can map the patient id to the real 
patient. 
5.2.Storage and queries with i2b2 
In order to import the data into the i2b2 database one needs to understand the 
way in which i2b2 is structuring the data. The Data CRC Cell of i2b2 takes care 
about the Data Mart and stores the data in a star format. The 
OBSERVATION_FACT is the central fact table of the database. Data in i2b2 is 
stored in an Entity-Attribute-Value (EAV) format. The entity in this case is the 
patient who is identified through the columns patient number (“patient_num”) 
and encounter number (“encounter_num”) as it can be seen in Figure 53. The 
attribute can be a classification (e.g. ICD-10) or a numeric value (e.g. age). 
Other dimension tables provide information about hospital visits 
(VISIT_DIMENSION) or additional patient information (PATIENT_DIMENSION), 
such as gender, age, race, etc.[36] 
So in order to import the information from REDCap one needs to export and 
convert it into the format of i2b2 first. This process is also known as Extraction, 
Transformation and Loading as described in chapter 2.3.3. For the sake of this 
use case only two patients have been created and their age and gender has 
been manually transformed into a format that can be imported to the i2b2 
database. Figure 54 shows the transformation of the REDCap output table into 
the OBSERVATION_FACT and PATIENT_DIMENSION tables. 
Once the data is stored in an i2b2 compatible format it can be directly imported 
into the PostgreSQL database. For this use case a CSV file with the data is 
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imported via the pgAdmin web based user interface of the PostgreSQL 
database (as shown in Figure 55). 
!  
Figure 53: The CRC Cell with its star schematics, filled with exemplary entries 
[37]. 
!  
!  
Once logged into the pgAdmin interface the prepared CSV files can be directly 
imported into the corresponding tables of the database. In order to test the 
Figure 54: Transformation of the REDCap output (top) to the 
OBERSERVATION_FACT (middle) and PATIENT_DIMENSION tables.
 A use case with REDCap and i2b2   
!42
successful import to the database a simple query for “male patients” with a 
patient age breakdown has been executed before and after the import. 
!  
Figure 55: Screenshot of the import via the web based pgAdmin interface of the 
PostgreSQL database. 
The query result for male patients is shown in Figure 56: Male patient query 
before data import.Figure 56. There are 82 male patients in the database. 
There are 28 patients in the range of 18-34 years and 8 in the range of 55 – 64 
years before the data import. 
After the import (Figure 57) we can see that the number of male patients has 
increased to 84 as well as each aforementioned age range (18-34 and 55-64 
years) has increased by one.  
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!  
Figure 56: Male patient query before data import. 
!  
Figure 57: Male patient query after the import. 
The results of this use case have been as accepted and it was possible to 
import two patients into the database and run a query for them successfully. 
More patient data (e.g. race, diagnosis, medication, etc.) can be imported into 
the database in the same way. 
5.3.Use case insights and future development 
The presented use case exemplifies a proof of concept that it is possible to 
collect patient data in an automated fashion via REDCap surveys and import 
them successfully into the i2b2 database. 
It should be mentioned that the installation process was more time consuming 
than expected because some of the tools and tutorials did not work as 
expected. A more detailed description can be found in Annex A2 – Installation 
process of i2b2 and hopefully gives helpful guidelines for future i2b2 
implementations. 
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Furthermore, in order to use these tools for a large-scale collection of patient 
data on a routine basis the import process to i2b2 needs to be automated. 
Different approaches seem possible to tackle this issue: One and most likely the 
easiest would be to make use of an available plugin within the i2b2 community 
for the import of REDCap data into i2b2. The feasibility still needs to be 
evaluated for this use case. Another solution could be to develop a custom SQL 
script to directly import the data into the database. 
Furthermore, another important aspect of the import routine is to develop a 
proper patient de-identification concept together with real world data. An 
evaluation of existing de-identification tools should be done. 
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CONCLUSIONS 
Overall the objectives of this thesis have been reached. An introduction to FMS 
and its impact on society has been given. Possible database technologies for 
the setup of an FMS patient database have been researched and the most 
feasible technology has been selected. 
Further a theoretical concept for the data collection, storage and analysis 
process of FMS patient information has been created. I2B2 offers a great 
possibility to enhance collaborated research. The graphical user interface 
makes the identification process of a cohort group simple, even for people who 
do not have a technical background. However, i2b2 turned out not to be the 
most optimal solution to gather patient on regular basis. Therefore, the data 
collection process with surveys should be done with REDCap, because it offers 
a simple and effective solution to create surveys and gather patient data. The 
collected data later can be imported to i2b2 foster research collaboration. 
The created use-case with REDCap as a data collection system and i2b2 as the 
main storage system showed that the creation of a FMS patient database is a 
viable task from a technical perspective. 
The business and legal analysis yielded into a not so simple answer. The 
expenses to maintain such a platform could be estimated and the legal 
obstacles evaluated. It remained difficult to estimate a correct number of 
potential customers and how much they would be willing to pay for this service. 
Legally it should be possible to run this platform, but the newly released GDPR 
increased the regulations and efforts to maintain it (e.g. the necessity of a 
DPO). 
Nevertheless, to create and properly role out the FMS patient database 
additional steps need to be taken into consideration: 
1. A concept for the whole ETL process remains to be created. Ideally an 
existing plugin for the import of REDCap data into i2b2 can be used but it 
needs to be thoroughly evaluated whether it complies with the data 
privacy regulations of the GDPR and whether it is a feasible solution for 
data collection on a regular basis. That means that doctors might want to 
add additional data for an already existent patient in the data and the 
patient id needs to be mapped with its actual patient. 
2. A REDCap license needs to be obtained. Also it is important to decide 
whether the organization will be run as a for profit or non-profit, because 
the REDCap license is only free of charge for non-profit organizations. 
3. A data security concept for i2b2 and REDCap is needed. All data has to 
be saved on the server encrypted and it should be evaluated whether the 
necessary standards for the medical field are met. 
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4. The legal regulation for data protection, especially with the GDPR must 
to be taken into consideration. Therefore an external expert in the field of 
data protection and GDPR can be consulted. 
5. Even though the cost for providing such a server has been calculated it is 
still unclear whether hospitals and research institutions are willing to pay 
for such a service and whether it would be enough to cover the 
expenses. Hence, an in depth market analysis is necessary on whether 
the service can be maintained with generated revenue or whether it will 
be constantly depending on public funding. 
Sustainability considerations 
The creation of a FMS patient database can have a highly positive economical 
and social impact on society. Such a central database can help to foster the 
research in the field of FMS. If research institutions and hospitals start sharing 
their data it would have a benefit for all participants. First of all they could save 
the effort of maintaining their own database locally and increase efficiency in 
collecting the patient data. In addition everybody’s research data would 
increase because one can tap into a network of medical patient data and 
enable research, which would have not been possible with a limited data set. A 
better research on FMS potentially helps to mitigate the impact of FMS on 
society and increase the efficiency of its treatment. Therefore a FMS patient 
database has more of an indirect impact on society as a whole, but can make a 
direct impact to medical research. 
This being said, the impact factor of the database highly depends on the 
acceptance of the users. The more users, therefore more data the higher the 
impact factor on research. 
Ethical considerations 
From an ethical the thesis does not violate any human rights. It rather helps with 
regard of the human right for health. The mass data collection of personal 
information could raise privacy issues. Since the collected information contains 
a person’s medical detail it is a very delicate matter. Therefore it is even more 
important to ensure the highest security standards possible and to only store 
de-identified information. It has to be guaranteed that due to the participation no 
harm is inflicted on any person. 
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ACRONYMS 
ACR   American College of Rheumatology 
API  Application Programming Interface 
CDW  Clinical Data Warehouse 
CDISC Clinical Data Interchange Standards Consortium 
CST  Hospital de Terrasa 
DPO  Data Protection Officer 
EAV  Entity-Attribute-Value 
EDC  Electronic Data Capture 
EHR   Electronic Health Records 
EIDP  Enterprise Integration and Development Platform Application 
ESID  European Society for Immunodeficiences 
EU   European Union 
FHIR  Fast Healthcare Interoperability Resources 
FIQ  Fibromyalgia Impact Questionnaire 
FMS  Fibromyalgia Syndrome 
GDPR  General Data Protection Regulation 
I2b2  Integrating Biology and the Bedside 
IDRT  Integrated Data Repository Toolkit 
IRB  Institutional Review Board 
NCATS National Center for Advancing Translational Sciences 
NHANES National Health and Nutrition Examination Survey 
NIH  National Institutes of Health 
NPL  Natural Language Processing 
ODM  Operational Data Model 
QEP  Query Entry Point 
RSU  Ridan Stradins University 
SHRINE Shared Health Research Information Network 
SHARP Strategic Health IT Advanced Research Project 
SPIN  Shared Pathology Information Network 
SS  Severity Scale 
TMF German Technology and Method Platform for Networked Medical 
Research 
UK Essen Universitätsklinikum in Essen 
VPS  Virtual Private Server 
WPI  Widespread Pain Index 
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Annexes 
A1 – List of possible FMS symptoms 
The symptoms of FMS are very diverse and incorporate restless sleep, fatigue, 
irritable bowel syndrome, cognitive disturbance, skin tenderness, post-
exertional pain, stiffness, irritable bladder syndrome, headaches, parenthesis, 
restless legs, mood disturbances, dizziness and fluid retention. 
A2 – Installation process of i2b2 
In the following the experience and issues occurred during the setup of i2b2 
shall be described and offer a potential guideline during the another installation 
of i2b2. 
The installation process of i2b2 on the UPC server turned out to be significantly 
more time consuming than it was expected. 
Two Docker installations from Docker Hub have been tested. One Docker 
image contained the i2b2 Wizard  (as described in 2.3.3) utilizing an Oracle 27
database as the underlying SQL database. The other Docker installation 
contained an i2b2 installation with an underlying PostgreSQL database and a 
WildFly  application server . 28 29
The automatic installation of the i2b2 Wizard Docker image was not working 
because it could not connect to the Oracle database. Therefore, the steps of the 
manual quick start guide  from the i2b2 community have been followed. After 30
about two days trial-and-error the i2b2 Wizard ran through successfully. The 
web client login worked but it was not possible to access the admin menu, to 
connect to the i2b2 Hive via the Workbench and to access the i2b2demodata on 
the Oracle database. 
The second Docker image caused less effort to execute. Three Docker images 
(i2b2/i2b2-web, i2b2/i2b2-wildfly and i2b2/i2b2-pg) for the web-interface WildFly 
application server and PostgreSQL database, from the i2b2 DockerHub, were 
used. After it was possible to log into the web client and admin menu. 
Nevertheless, a connection to the Workbench still was not possible. 
 https://hub.docker.com/r/cyberseb/i2b2/ , accessed July 20th, 201827
 http://wildfly.org/ , accessed July 20th, 201828
 https://hub.docker.com/u/i2b2/ , accessed July 20th, 201829
 http://community.i2b2.org/wiki/display/IDRT/260.+i2b2+Wizard+quick+start, accessed June 30
4th, 2018
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In a conversation with Sebastian Mate (the developer of the i2b2 Wizard) he 
confirmed that the version of the i2b2 Wizard has not been updated for some 
time and is not completely compatible with the latest i2b2 software. 
Furthermore, he provided additional information about his experience with the 
i2b2 setup and in general information about i2b2 and its data structure. 
Hence, the decision was made to continue with the second Docker image, 
which caused less trouble during the installation process and allowed more 
access to i2b2. 
The connection with the Workbench was tested from different computers with 
different operating systems (Windows and a provided Ubuntu Virtual Box image 
from Mac OS X). The connection the to installed version on the UPC server as 
well as to the test server provided by i2b2 was unsuccessful. 
On the official website of i2b2  the client software, a Client & Server VMWare 31
image and the i2b2 source code are provided. In order to rule out connection 
issues, locked ports or a firewall blocking access, the next step was to utilize 
the Client & Server VMWare image provided by i2b2. The guidelines 
recommendation is to use VMware server 1.0.5 or higher. When using the 
referenced link once becomes to know that the VMware server product line 
does not exist anymore. VMware has only a few products to offer that are free 
of charges and others in the range of 500 – 3000 USD per year. Testing on 
Windows, MAC OS X and Ubuntu with the available VMware products and the 
virtualization software VirtualBox were not successful. 
Since i2b2 is an open-source system there is no dedicated support team 
available to assist with i2b2 issues. Nevertheless there is a JIRA Bug tracking 
system  to report issues (which eventually somebody will fix), there is a Google 32
discussion group  to help with the installation of i2b2 and there is the i2b2 33
community wiki . So with some time and dedication it is possible to gather the 34
information needed to get the system running. 
The login issues for the Workbench have been fixed, but after that the import 
plugin for i2b2 did not work. Since at this point more understanding about the 
database structure of i2b2 was present, the decision was made to directly 
import the patient data into the PostgreSQL database. It also makes more 
sense to directly work with the database because to (later) provide an 
automated system for import of data into i2b2 either a personally developed 
SQL script or an existing ETL solution should be used with some adaption. 
 https://www.i2b2.org/software/index.html , May 3rd, 201831
 http://community.i2b2.org/jira/browse/ , September 10th, 201832
 https://groups.google.com/forum/#!forum/i2b2-install-help , September 10th, 201833
 https://community.i2b2.org/ , July 10th, 2018 34
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To summarize, it is good to know that there is a group discussion and issue 
tracking system present, which can help with the installation of i2b2. 
Furthermore, one should also bring some patience, because with an open-
source system not everything is always working as expected and some sources 
might be not available temporarily.
